Mixed Close For 3 Stocks: Seadrill Ltd(SDRL), ICICI Bank Ltd (IBN) and Rich Pharmaceuticals Inc(RCHA)

Posted by Saimoon February 5, 2015 0 Comment 1806 views


New York, NY – GDP INSIDER  –  02/05/2015.

This article discusses three companies: Seadrill Ltd(NYSE:SDRL), ICICI Bank Ltd (ADR)(NYSE:IBN) and Rich Pharmaceuticals Inc(OTCBB:RCHA)

Seadrill Ltd(NYSE:SDRL) saw its value decline by 5.07% during yesterday’s trading. The stock fell sixty five cents to finish the day at a closing price of $12.16, following the American Petroleum Institute’s data which showed that U.S. crude stocks was climbed by more than 6 million barrels last week to their highest level in 80 years. Bermuda-based offshore drilling contractor also lost an additional fifteen cents during afterhours trading. Despite the loss in value, Seadrill Ltd had a trading volume of 19.40 million, which is substantially higher than its 30-day average trading volume of 13.99 million.

Can Seadrill Ltd Dig Itself Out Of Its Current Hole? Receive A Free SDRL Trend Report To Make A Savvy Investment Plan.

ICICI Bank Ltd (ADR)(NYSE:IBN) suffered a rather small loss yesterday as the stock only declined 1.73% to finish the day at a closing price of $11.36. The $32.39 billion market cap stock remains just under $1.88 below its one year high of $13.24. India-based banking company had an unusual high trading volume of 18.18 million, a figure which is 11.8 million higher than its 3-month average trading volume of 6.38. ICICI Bank Ltd has a debt-to-equity ratio of 2.29, which implies that the stock depends on outside capital to finance its growth.

Why Is ICICI Bank Ltd’s Debt-To-Equity Ratio So High? Read Our Free IBN Report To Know More.

Rich Pharmaceuticals Inc(OTCBB:RCHA) soared to new heights as the stock saw a huge gain of 1544.44% during yesterday’s trading to close the day at a new closing price of $0.0139. Despite the substantial increase in value, the biopharmaceutical company sits $0.4452 below its 52 week high of $0.46. Rich Pharmaceuticals Inc, formerly Nepia, Inc, is a California-based biopharmaceutical company, focuses on the development of PD-616 for the treatment of Acute Myelogenous Leukemia (AML). The stock had a huge trading volume of 206.17 million, a figure which is 200.45 million greater than its 30-day average trading volume of 5.72 million.

What Has Caused Rich Pharmaceuticals Inc To Spike Its Volume? Learn More About Company’s Trajectory In Our Free RCHA Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment